CN100376282C - 一种治疗脾胃不和、可开胃健脾的药物 - Google Patents
一种治疗脾胃不和、可开胃健脾的药物 Download PDFInfo
- Publication number
- CN100376282C CN100376282C CNB2004100228692A CN200410022869A CN100376282C CN 100376282 C CN100376282 C CN 100376282C CN B2004100228692 A CNB2004100228692 A CN B2004100228692A CN 200410022869 A CN200410022869 A CN 200410022869A CN 100376282 C CN100376282 C CN 100376282C
- Authority
- CN
- China
- Prior art keywords
- spleen
- parts
- present
- oral liquid
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 210000000952 spleen Anatomy 0.000 title claims abstract description 37
- 230000036528 appetite Effects 0.000 title claims abstract description 14
- 235000019789 appetite Nutrition 0.000 title claims abstract description 14
- 229940079593 drug Drugs 0.000 title description 40
- 210000002784 stomach Anatomy 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000341 volatile oil Substances 0.000 claims abstract description 21
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 238000001256 steam distillation Methods 0.000 claims abstract description 9
- 206010003591 Ataxia Diseases 0.000 claims abstract description 8
- 206010010947 Coordination abnormal Diseases 0.000 claims abstract description 8
- 208000016290 incoordination Diseases 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 229940126701 oral medication Drugs 0.000 claims abstract description 6
- 230000001737 promoting effect Effects 0.000 claims abstract description 6
- 238000005728 strengthening Methods 0.000 claims abstract description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 98
- 239000000706 filtrate Substances 0.000 claims description 22
- 241000756943 Codonopsis Species 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 17
- 239000000796 flavoring agent Substances 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000012676 herbal extract Substances 0.000 claims description 10
- 239000010271 massa medicata fermentata Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000004062 sedimentation Methods 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 4
- 239000004334 sorbic acid Substances 0.000 claims description 4
- 229940075582 sorbic acid Drugs 0.000 claims description 4
- 235000010199 sorbic acid Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 230000010412 perfusion Effects 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 8
- 238000011161 development Methods 0.000 abstract description 3
- 239000008492 tangshen Substances 0.000 abstract 3
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 26
- 238000012360 testing method Methods 0.000 description 15
- 239000006187 pill Substances 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 241000700159 Rattus Species 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- 102100030659 Lipase member I Human genes 0.000 description 10
- 101710102461 Lipase member I Proteins 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000003405 ileum Anatomy 0.000 description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 5
- 229940012189 methyl orange Drugs 0.000 description 5
- 230000003285 pharmacodynamic effect Effects 0.000 description 5
- 238000001291 vacuum drying Methods 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 102000057297 Pepsin A Human genes 0.000 description 4
- 108090000284 Pepsin A Proteins 0.000 description 4
- 239000003463 adsorbent Substances 0.000 description 4
- 230000030136 gastric emptying Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 229940111202 pepsin Drugs 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002489 hematologic effect Effects 0.000 description 3
- 230000003118 histopathologic effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000011889 obduction Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(g生药/kg) | 药前体重(g) | 药后体重(g) | 增加值(g) |
正常对照组脾虚模型组开胃理脾丸本发明口服液本发明口服液本发明口服液儿康宁 | --3.21.63.26.46.2ml/kg | 20.25±1.6520.10±1.3920.40±1.4320.35±1.3320.10±1.2019.95±1.7120.30±1.36 | 23.25±2.0421.35±1.81**23.00±2.11<sup>#</sup>22.10±1.90<sub>Δ</sub><sup>#</sup>22.70±1.23<sub>Δ</sub><sup>#</sup>22.75±1.98<sub>Δ</sub><sup>#</sup>22.95±1.62<sub>Δ</sub><sup>#</sup> | 3.00±0.781.25±0.82***2.60±0.84<sup>###</sup>1.75±0.72<sup>ΔΔ# </sup>2.60±0.74<sub>Δ</sub><sup>###</sup>2.80±0.79<sub>Δ</sub><sup>###</sup>2.65±0.71<sup>###</sup> |
组别 | 剂量(g生药/kg) | 推进率(%) |
正常对照组脾虚模型组开胃理脾丸本发明口服液本发明口服液本发明口服液儿康宁 | --3.21.66.415.26.2ml/kg | 88.68±8.4075.39±9.41***85.14±9.87<sup>##</sup>83.69±8.86<sub>Δ</sub><sup>#</sup>86.57±7.25<sub>Δ</sub><sup>###</sup>88.85±7.83<sub>Δ</sub><sup>###</sup>87.56±9.24<sup>###</sup> |
组别 | 剂量(g/kg) | 胃液量(ml) |
正常对照组开胃理脾丸本发明口服液本发明口服液本发明口服液儿康宁 | -1.40.71.42.82.9ml/kg | 1.92±0.242.18±0.38*2.17±0.32<sub>Δ</sub><sup>*</sup>2.25±0.25<sub>Δ</sub><sup>***</sup>2.36±0.26<sub>Δ</sub><sup>***</sup>2.14±0.28* |
组别 | 剂量(g/kg) | 游离酸(mmol/L) | 总酸度(mmol/L) | 总酸排出量(μmol/h) |
正常对照组开胃理脾丸本发明口服液本发明口服液本发明口服液儿康宁 | -1.40.71.42.82.9ml/kg | 58.44±5.4867.48±9.14**61.22±6.36<sub>Δ</sub><sup>*</sup>66.08±8.62<sub>Δ</sub><sup>**</sup>69.64±11.28<sub>Δ</sub><sup>**</sup>66.92±8.88** | 67.04±6.5274.10±8.68*69.70±7.14<sub>Δ</sub><sup>*</sup>74.64±8.12<sub>Δ</sub><sup>**</sup>75.64±11.04<sub>Δ</sub><sup>**</sup>73.12±8.30* | 64.31±8.8280.38±14.48***76.29±17.14<sub>Δ</sub><sup>*</sup>83.84±12.38<sub>Δ</sub><sup>***</sup>88.21±14.84<sub>Δ</sub><sup>***</sup>78.68±12.80*** |
组别 | 剂量(g/kg) | 胃蛋白酶活性(u/ml) | 胃蛋白酶排出量(u/h) |
正常对照组开胃理脾丸本发明口服液本发明口服液本发明口服液儿康宁 | -1.40.71.42.82.9ml/kg | 478.14±76.00547.06±57.24**512.70±66.75<sub>Δ</sub><sup>*</sup>556.36±87.42<sub>Δ</sub><sup>**</sup>647.88±88.43<sub>ΔΔΔ</sub><sup>***</sup>572.32±72.36** | 456.09±79.36595.48±117.43***554.94±92.25<sub>Δ</sub><sup>**</sup>626.98±131.66<sub>Δ</sub><sup>***</sup>763.33±125.62<sub>ΔΔΔ</sub><sup>***</sup>604.10±108.42*** |
组别 | 剂量(g生药/kg) | 胃残留率(%) |
对照组开胃理脾丸本发明口服液本发明口服液本发明口服液 | -3.21.63.26.4 | 30.47±4.8326.69±4.10*28.87±5.31*25.86±4.07**24.91±3.59** |
组别 | 剂量(g/ml) | 收缩频率(次/min) | 收缩幅度(mm) |
对照组乙酰胆碱组本发明口服液本发明口服液本发明口服液 | -0.0010.10.20.4 | 9.2±1.011.1±1.4***9.7±1.3*10.0±1.8*10.5±1.6** | 3.1±1.613.4±5.7***3.6±1.8*4.9±1.6**6.2±2.7*** |
组别 | 药物浓度(g/ml) | 给药体积(ml/kg) | 剂量(g/kg) | 动物数(只) | 死亡动物数(只) | |
1天 | 2~7天 | |||||
口服液丸剂 | 2.60.2 | 4040×3 | 10424 | 2020 | 00 | 00 |
组别 | 药物浓度(g/ml) | 给药体积(ml/kg) | 剂量(g/kg) | 动物数(只) | 体重变化(g) | |
实验前 | 第7天 | |||||
口服液丸剂 | 2.60.2 | 4040×3 | 10424 | 2020 | 20.28±1.3120.53±1.37 | 23.68±1.4423.60±1.57 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100228692A CN100376282C (zh) | 2004-02-06 | 2004-02-06 | 一种治疗脾胃不和、可开胃健脾的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100228692A CN100376282C (zh) | 2004-02-06 | 2004-02-06 | 一种治疗脾胃不和、可开胃健脾的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1650915A CN1650915A (zh) | 2005-08-10 |
CN100376282C true CN100376282C (zh) | 2008-03-26 |
Family
ID=34868398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100228692A Expired - Lifetime CN100376282C (zh) | 2004-02-06 | 2004-02-06 | 一种治疗脾胃不和、可开胃健脾的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100376282C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104127759A (zh) * | 2014-07-16 | 2014-11-05 | 湖南九典制药有限公司 | 一种具有开胃健脾功效的药物的制备方法 |
CN104474385A (zh) * | 2014-11-30 | 2015-04-01 | 顾蔷怡 | 一种治疗脾胃不和的药物及其制备方法 |
CN104857418B (zh) * | 2015-05-14 | 2019-01-22 | 成都市康飞药业有限公司 | 一种健脾开胃的药物组合物及其制备方法和用途 |
-
2004
- 2004-02-06 CN CNB2004100228692A patent/CN100376282C/zh not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
开胃理脾丸. 中华人民共和国卫生部药典委员会.中华人民共和国卫生部药品标准中药成方制剂,第7期. 1993 * |
Also Published As
Publication number | Publication date |
---|---|
CN1650915A (zh) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100453105C (zh) | 一种具有通便排毒、减肥降脂功能的组合物及制备方法 | |
CN102343023B (zh) | 药物组合物及其制备方法和用途 | |
CN101091765A (zh) | 药物组合物及其预防和治疗糖尿病的用途 | |
CN101352512B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN107997176A (zh) | 一种防治小儿积食厌食的健胃消食保健食品 | |
CN104338044A (zh) | 治疗妇科白带异常的药物及其制备方法 | |
CN105287812B (zh) | 一种治疗肠易激综合征的药物组合物及其用途 | |
CN101317964B (zh) | 具有健脾补肾功效的中药组合物及其制备方法和其用途 | |
CN101002929A (zh) | 一种治疗功能性消化不良或并发幽门螺旋杆菌感染的药物及其制备方法 | |
CN101461932B (zh) | 一种治疗小儿脾虚湿热腹泻的药物组合物及其制备方法 | |
CN100376282C (zh) | 一种治疗脾胃不和、可开胃健脾的药物 | |
CN102048841B (zh) | 一种具有催乳作用的中药组合物及其制备工艺 | |
CN102430009B (zh) | 治疗胃肠疾病中药组合物及其制备方法 | |
CN102430008B (zh) | 治疗胃肠疾病中药组合物及其制备方法 | |
CN102188522A (zh) | 一种治疗便秘的中药组合物 | |
CN110522841B (zh) | 一种中药组合物及其制备方法、用途 | |
CN1709340B (zh) | 一种用于补养心肾、健脑安神的药物组合物及其制备方法和用途 | |
CN101229329A (zh) | 化积片及其生产工艺方法 | |
CN103191243A (zh) | 由黄连、吴茱萸组成的药物组合物的用途及其制备方法 | |
CN110354196A (zh) | 一种中药组合物及其制备方法和用途 | |
CN102631422B (zh) | 一种治疗急慢性肠胃炎的药物组合物 | |
CN102151305A (zh) | 文冠果提取物、其提取方法及其用途 | |
CN102430075B (zh) | 治疗胃肠疾病中药组合物及其制备方法 | |
CN102416088B (zh) | 治疗胃肠疾病中药组合物及其制备方法 | |
CN100563685C (zh) | 一种治疗慢性便秘的中成药-苁蓉通便制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 410005, Hunan, Changsha province Furong Road, No. 368 BOBO world city CTA wealth center, 24 floor Patentee after: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Address before: 410331 Liuyang Liuyang bio pharmaceutical Park Hunan Hunan nine Pharmaceutical Co., Ltd. Patentee before: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 410205 8th floor, building A1, Lugu science and Technology Industrial Park, Wukuang, No.28, Ludian Road, Yuelu District, Changsha City, Hunan Province Patentee after: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Address before: 410005, Hunan, Changsha province Furong Road, No. 368 BOBO world city CTA wealth center, 24 floor Patentee before: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: No.1, Jiankang Avenue, Liuyang Biomedical Park, Liuyang City, Changsha City, Hunan Province Patentee after: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. Address before: 410205 8th floor, building A1, Lugu science and Technology Industrial Park, Wukuang, No.28, Ludian Road, Yuelu District, Changsha City, Hunan Province Patentee before: HUNAN JIUDIAN PHARMACEUTICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CX01 | Expiry of patent term |
Granted publication date: 20080326 |
|
CX01 | Expiry of patent term |